F · Healthcare

NFL BIOSCIENCES EO -03 (82F)

Biotechnology

NFL BIOSCIENCES EO -03 (82F) is listed on F in the Healthcare sector. Industry: Biotechnology. As of 2026-05-23, reported P/E ratio is 25.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.

Download on the App Store Get it on Google Play

Key metrics for 82F

P/E ratio

25.00

NFL BIOSCIENCES EO -03 (82F) — FAQ

What is 82F's P/E ratio?

The price-to-earnings (P/E) ratio for NFL BIOSCIENCES EO -03 (82F) is 25.00 (data as of 2026-05-23).

Does NFL BIOSCIENCES EO -03 pay a dividend?

Dividend yield is not available in the current snapshot for NFL BIOSCIENCES EO -03 (82F). Check the MyAverix Finance app for the latest dividend data.

What sector is NFL BIOSCIENCES EO -03 in?

NFL BIOSCIENCES EO -03 (82F) is classified in the Healthcare sector (Biotechnology industry).

What exchange is 82F listed on?

82F is listed on F.

Full report in the app

Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.

Related Healthcare companies

Abbott Laboratories (ABT) AbbVie Inc. CDR (ABBV) Agilent Technologies Inc. (A1GI34) Aimed Bio (0009K0) Alnylam Pharmaceuticals, Inc. (A1LN34) Alvotech (ALVO) Amgen Inc (AMGN34) argenx SE (A1RG34)